BioMedWire Stocks

Prime Day 2024 Is Massive Success for Amazon as American Buyers Spend $14B-Plus

July 16, 2024, marked the beginning of this year’s Amazon Prime Day, which established a new record in online shopping. The annual two-day sale, which ended on July 17, saw consumers in America spend more than $14 billion.

This year’s figure represents an 11% rise in consumer spending, as 2023’s total consumer spending stood at $12.7 billion. On the first day of the sale, $7.2 billion was spent by consumers. During the same period in 2023, consumers spent 11.2% less. The momentum grew on day two of the sale, with consumer spending hitting $7 billion.

Amazon released a statement confirming the success of Prime Day 2024 but did not release detailed figures. The e-commerce company also saw an increase in mobile shopping, with purchases made through phones making up 18% of total sales, indicating a shift toward mobile commerce.

Rufus, a generative AI-powered shopping assistant trained on the company’s product information and catalogue, played an important role in helping millions of consumers by giving order updates and offering product recommendations. This AI assistant, which was launched to all consumers in the United States before prime day, demonstrated the growing integration of AI in improving shopping as an experience.

The top categories that drove sales on Prime Day 2024 were furniture and electronics, with customers making the most of the discounts to upgrade their personal tech as well as their homes.

Adobe Digital Insight’s lead analyst, Vivek Pandya, explained that the huge discounts offered during Prime Day were a stimulus for customer spending, particularly in the furniture, apparel and electronics categories. Prior to the sale, these categories had recorded moderate growth in the months before. Data from the e-commerce company also revealed that back-to-school shopping contributed significantly to total consumer spending.

The Buy now, Pay later offering from Amazon made up $1.08 billion of total sales, which equates to 7.6%. This method of payment has grown popular, allowing customers more flexibility in their purchases.

Numerator data estimates that the average order value during this Prime Day was $57.97. This is higher than the 2022’s and 2023’s averages, which stood at $53.14 and $56.64, respectively. This means that customers were willing to spend more per purchase, which may have been because of the different products available and/or the attractive deals offered.

Prime Day has a significant impact on the global e-commerce market, driving sales for retailers that promote their products during this sale period and bringing in additional revenue for Amazon.

This huge success registered by Amazon should push other players such as NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) to aim for even greater success as they deploy cutting-edge technologies in their bid to expand their reach both among sellers and buyers.

NOTE TO INVESTORS: The latest news and updates relating to NextPlat Corp. (NASDAQ: NXPL, NXPLW) are available in the company’s newsroom at https://ibn.fm/NXPL

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Soligenix Inc. (NASDAQ: SNGX) Expands European Medical Advisory Board, Advances Phase 3 Study to Support HyBryte(TM) Development for CTCL

The expansion of Soligenix’s European Medical Advisory Board underscores the company's commitment to delivering innovative…

19 hours ago

Scientists Stunned Upon Discovering Glioblastoma Erodes Skull Tissue

For long, treatment approaches to glioblastoma, the deadliest form of brain cancer, have assumed that…

21 hours ago

Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Expands Commercialization Strategy with $375K Financing, Investor Awareness Agreements, and Breakthrough Personalized Radiation Dose Breast CT

Izotropic Corp. marks a significant milestone in breast imaging with its patent-pending personalized radiation dose…

2 days ago

Oncotelic Therapeutics Inc.’s (OTLC) Sapu003: Injectable Everolimus (Afinitor(R)) to Begin Clinical Trials, Aiming to Boost Drug Bioavailability

Oncotelic Therapeutics developed the Deciparticles(TM) technology to improve the bioavailability of drugs, largely thanks to…

2 days ago

HeartBeam Inc. (NASDAQ: BEAT) Validates ECG Technology with Strong Results in Pivotal Study

HeartBeam is developing a portable, credit-card-sized device and proprietary software capable of capturing heart signals…

3 days ago

Lund University Researchers Discover Why Leukemia Cells Evade the Immune System

While immunotherapy has scored a significant level of success in treating many types of cancer,…

3 days ago